Cargando…

Cardiac Arrhythmias in Oncological Patients—Epidemiology, Risk Factors, and Management within the Context of the New ESC 2022 Guidelines

PURPOSE OF REVIEW: To provide an update on epidemiology, risk factors, and management of cardiac arrhythmias in oncological patients within the context of the new European Society of Cardiology 2022 guidelines on cardio-oncology. RECENT FINDINGS: One of the side effects of different chemotherapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gawlik, Michał, Zimodro, Jakub Michal, Gąsecka, Aleksandra, Filipiak, Krzysztof J., Szmit, Sebastian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556148/ https://www.ncbi.nlm.nih.gov/pubmed/37589940 http://dx.doi.org/10.1007/s11912-023-01445-x

Ejemplares similares

The ESC 2022 Cardio-Oncology Guidelines and the Road Ahead in Cardio-Oncology
por: Cheng, Richard K., et al.
Publicado: (2022)

Emerging Role of Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease—Insights from the 2022 ESC Guidelines
por: Banaszkiewicz, Marta, et al.
Publicado: (2023)

Comment on the ESC Guidelines 2022 for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
por: Cuervo, David Calvo
Publicado: (2023)

The Potential Impact of the 2022 ESC Cardio-Oncology Guidelines on Clinical Practice in China
por: Tse, Gary, et al.
Publicado: (2023)

Spotlight on the 2022 ESC guideline management of ventricular arrhythmias and prevention of sudden cardiac death: 10 novel key aspects
por: Könemann, Hilke, et al.
Publicado: (2023)

AngioScore: An artificial intelligence tool to assess coronary artery lesions
por: Blazejowska, Ewelina, et al.
Publicado: (2023)

Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID-19: A systematic review and meta-analysis
por: Szarpak, Lukasz, et al.
Publicado: (2022)

ESC Cardio-Oncology Guidelines: A Triumph—But Are We Overscreening?
por: Witteles, Ronald M., et al.
Publicado: (2022)

ACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison
por: Behnoush, Amir Hossein, et al.
Publicado: (2022)

How to Maintain Safety and Maximize the Efficacy of Cardiopulmonary Resuscitation in COVID-19 Patients: Insights from the Recent Guidelines
por: Chojecka, Dominika, et al.
Publicado: (2021)

ESC Congress 2022 Imaging Highlights
por: Puntmann, Valentina O, et al.
Publicado: (2023)

Correlation between takotsubo cardiomyopathy and SARS-CoV-2 infection
por: Szarpak, Lukasz, et al.
Publicado: (2021)

The ESC Cardio-Oncology Guidelines: A Roadmap for Clinical Practice and Generating Needed Evidence
por: Sparano, Joseph A., et al.
Publicado: (2022)

The Ketogenic Effect of SGLT-2 Inhibitors—Beneficial or Harmful?
por: Koutentakis, Michail, et al.
Publicado: (2023)

Correction: Pluta et al. Platelet–Leucocyte Aggregates as Novel Biomarkers in Cardiovascular Diseases. Biology 2022, 11, 224
por: Pluta, Kinga, et al.
Publicado: (2022)

Milrinone or dobutamine in patients with heart failure: evidence from meta‐analysis
por: Szarpak, Lukasz, et al.
Publicado: (2022)

LDL-Cholesterol and Platelets: Insights into Their Interactions in Atherosclerosis
por: Gąsecka, Aleksandra, et al.
Publicado: (2021)

Post-COVID-19 heart syndrome
por: Gasecka, Aleksandra, et al.
Publicado: (2021)

Predictors of outcomes in mild pulmonary hypertension according to 2022 ESC/ERS Guidelines: the EVIDENCE-PAH UK study
por: Karia, Nina, et al.
Publicado: (2023)

Who are patients classified within the new terminology of heart failure from the 2016 ESC guidelines?
por: Delepaul, Benoit, et al.
Publicado: (2017)

Abbreviated lipid guidelines for clinical practice: Based on ESC lipid guidelines 2019 and ESC cardiovascular disease prevention in clinical practice guidelines 2021
por: Maher, Vincent, et al.
Publicado: (2023)

hESC-Derived Cardiomyocytes Electrically Couple and Suppress Arrhythmias in Injured Hearts
por: Shiba, Yuji, et al.
Publicado: (2012)

SECURE, ADVOR and REVIVED: Clinical Trials Presented at ESC 2022
por: Mendieta, Guiomar
Publicado: (2022)

P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets
por: Gasecka, Aleksandra, et al.
Publicado: (2020)

Relationship between clinical data and gene expression in the HER2/ErbB2-dependent signaling pathway in patients with acute heart failure
por: Szmit, Sebastian, et al.
Publicado: (2013)

The Effect of a Vegan Diet on the Cardiovascular System
por: Koutentakis, Michail, et al.
Publicado: (2023)

The 2022 European Society of Cardiology Cardio-oncology Guidelines in Focus
por: Gent, David G, et al.
Publicado: (2023)

Chemokine C-C Motif Ligand 7 (CCL7), a Biomarker of Atherosclerosis, Is Associated with the Severity of Alopecia Areata: A Preliminary Study
por: Waśkiel-Burnat, Anna, et al.
Publicado: (2021)

Comparison of ESC and ACC/AHA guidelines for myocardial revascularization
por: Stirrup, Jim, et al.
Publicado: (2017)

The 2020 ESC Guidelines on the Diagnosis and Management of Atrial Fibrillation
por: Kotalczyk, Agnieszka, et al.
Publicado: (2021)

Efficacy and safety of levosimendan and dobutamine in heart failure: A systematic review and meta-analysis
por: Jaguszewski, Milosz J., et al.
Publicado: (2021)

ESC-Leitlinien 2022: neue Leitlinien und neue Herausforderungen in Europa
por: Dörr, Rolf, et al.
Publicado: (2023)

Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment
por: Skwarek, Aleksandra, et al.
Publicado: (2021)

Angiotensin System Inhibitors May Improve Outcomes of Patients With Castration-Resistant Prostate Cancer During Abiraterone Acetate Treatment—A Cardio-Oncology Study
por: Wilk, Michał, et al.
Publicado: (2021)

Risk assessment in pulmonary arterial hypertension: A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines
por: Ahmed, Abdulla, et al.
Publicado: (2023)

What we have learned from the ESC position paper on arrhythmias in acute coronary syndromes
por: Görenek, Bülent, et al.
Publicado: (2015)

Antiplatelet Effects of PCSK9 Inhibitors in Primary Hypercholesterolemia
por: Pęczek, Piotr, et al.
Publicado: (2021)

Antiplatelet effects of prostacyclin analogues: Which one to choose in case of thrombosis or bleeding?
por: Rogula, Sylwester P., et al.
Publicado: (2020)

A Dutch perspective on the ESC/EACTS guidelines on myocardial revascularisation
por: Claessen, B.E., et al.
Publicado: (2015)

Atrial fibrillation: a geriatric perspective on the 2020 ESC guidelines
por: Polidori, M. Cristina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_li351t08p725cck7nl4kuijrhn